Romanian drug maker’s profit rises by over a third
Romanian drug producer Biofarm increased its net profit by 38% in the first quarter of 2015 compared to the same period of last year, to EUR 3.06 million. The company’s sales went up by almost a quarter (24.5%) to EUR 10.3 million. Three…
Romania Insider · Journalist
· Updated · 1 min read
Romanian drug producer Biofarm increased its net profit by 38% in the first quarter of 2015 compared to the same period of last year, to EUR 3.06 million. The company’s sales went up by almost a quarter (24.5%) to EUR 10.3 million. Three local investment funds, SIF Muntenia, SIF Banat-Crisana and SIF Moldova control over 77% of the company. Biofarm’s shares are trading on the Bucharest Stock Exchange where the company currently values EUR 70.4 million. editor@romania-insider.com
Free newsletters
Romania, in your inbox before your first coffee.
Get the Daily — the morning briefing, free, in English, unsubscribe anytime. Want business, real estate or travel digests too? Pick your newsletters →
